Skip to main content

Table 2 Odds ratios for muscle-invasive bladder cancer at diagnosis comparing antidepressant users to non-users

From: Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes

  Complete case analysis 2011–2015
Muscle-invasive (pT2+) Non-muscle-invasive (pT1) Unadjusted
odds ratio (95% CI)
Adjusteda
odds ratio (95% CI)
  Unadjusted
odds ratio (95% CI)
Adjusteda
odds ratio
(95% CI)
n % n %
Non-users (n = 7392) 3854 52.1 3538 47.9 Ref. Ref. Non-users (n = 3938) Ref. Ref.
AD users (n = 860) 437 50.8 423 49.2 0.95
(0.82–1.09)
0.86
(0.74–0.99)
AD users (n = 490) 0.96
(0.79–1.16)
0.87
(0.71–1.05)
  1. Results of complete case analysis (2005–2015) and when restricting the analysis to 2011 through 2015. AD antidepressant, CI confidence interval. aAdjusted for age, sex, CCI, alcohol-related disorders, and marital status